UC Announces Opening of Medical Screening Program in Portsmouth
In 1993, the U.S. Congress enacted Section 3162 of the Defense Authorization Act, which directed the Department of Energy (DOE) to initiate programs to evaluate the health of former DOE defense nuclear facility workers. That bill is the reason that a new medical screening program is opening in Portsmouth, Ohio.
A consortium led by Eula Bingham, PhD, professor emeritus, environmental health, at the UC Medical Center, and including the National Building & Construction Trades research arm, The Center to Protect Workers' Rights, Duke University, and Zenith Administrators, has been providing medical screening of former construction workers at the Oak Ridge Reservation since 1999. This consortium will begin to provide screening exams for former Portsmouth Gaseous Diffusion Plant (GDP) construction workers in January 2004.
The opening of the Outreach Office for the Portsmouth Gaseous Diffusion Plant Construction Workers Medical Screening Program will be held at 2:00 p.m. on Thursday, December 11, at the Plumbers and Pipefitters Local Union #577 Hall at 1236 Gallia St. in Portsmouth, Ohio.
Former Portsmouth GDP construction workers may call 1-888-464-0009 for more information.
Tags
Related Stories
UC experts say proper produce washing is key defense against Cyclospora
July 17, 2026
Hamilton County Public Health reports confirmed cases of cyclosporiasis, as concerns persist. Cyclospora is a parasite that can cause a stomach illness lasting days — sometimes even weeks. University of Cincinnati medical experts say it is usually linked to contaminated water or food, often fresh produce.
UC students organize free health clinic in community
July 15, 2026
The University of Cincinnati student chapter of Remote Area Medical held its annual free health clinic July 11-12 at St. Xavier High School. Medical, dental and vision care was offered to adults and children, with no income requirements or insurance needed.
University of Cincinnati advances FLASH radiation therapy with new clinical trial
July 15, 2026
UC Cancer Center researchers led the FAST-02 trial, showing ultra-high-dose-rate FLASH proton therapy near the heart and lungs safely reduced pain from thoracic bone metastases.